Block Admission Application & Exercise of Options | 21-Mar-2023 | 07:00 | RNS |
Director/PDMR Share Purchases | 06-Feb-2023 | 07:00 | RNS |
Trading Update | 31-Jan-2023 | 07:00 | RNS |
Holding(s) in Company | 30-Jan-2023 | 13:14 | RNS |
Holding(s) in Company | 18-Jan-2023 | 13:14 | RNS |
Holding(s) in Company | 18-Jan-2023 | 12:22 | RNS |
Holding(s) in Company | 17-Jan-2023 | 17:54 | RNS |
Holding(s) in Company | 17-Jan-2023 | 16:06 | RNS |
Holding(s) in Company | 13-Jan-2023 | 17:09 | RNS |
Acquisition of Winterlight Labs Inc | 11-Jan-2023 | 07:00 | RNS |
Strategic Partnership for Chinese Market Expansion | 24-Nov-2022 | 07:00 | RNS |
£1.1 million eCOA contract win | 19-Oct-2022 | 07:00 | RNS |
Acquisition of eClinicalHealth Limited | 12-Oct-2022 | 07:00 | RNS |
Interim Results | 20-Sep-2022 | 07:00 | RNS |
£2.2m neurodegenerative disease trial contr... | 01-Sep-2022 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 48.36p |
Change Today | -0.14p |
% Change | -0.29 % |
52 Week High | 104.00 |
52 Week Low | 47.00 |
Volume | 49,510 |
Shares Issued | 35.15m |
Market Cap | £17.00m |
RiskGrade | 282 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
11:12 | 30,570 @ 47.00p |
11:10 | 10,573 @ 47.35p |
10:56 | 5,444 @ 47.55p |
10:40 | 2,000 @ 48.00p |
10:40 | 1 @ 47.00p |
Chair | Steven John Powell |
CEO | Matthew Stork |
CFO | Stephen Symonds |
You are here: research